Page index

Subsequent Events

Subsequent Events

Effective March 1, 2013 Fresenius Medical Care has appointed a new Member of the Management Board responsible for research and development. Until the annual report’s editorial deadline, no further significant events took place.

Changes in the management board

Effective March 1, 2013 Fresenius Medical Care has expanded its Management Board and has appointed Dr. Olaf Schermeier as new Member of the Management Board being responsible for our global research and development activities. It is important for our future to continue to ensure market-oriented product innovations and at the same time to further increase the efficiency of our processes on a global basis. For this reason, we created the new role Chief Officer of Global R & D. Dr. Schermeier has many years of experience in various areas of the health care industry. Since 2004 he has served in a senior management position for the German company Dräger Medical.

No further significant events took place between the closing date of December 31, 2012, and the annual report’s editorial deadline of March 13, 2013. There were no fundamental changes in the economic and business environment in our field of activity.

We are currently not planning any major changes in Fresenius Medical Care’s organizational structure, administration, legal form or with regard to personnel which could lead to a significant impairment of the asset, financial and earnings situation of our Company.

Overall assessment of the business situation

Fresenius Medical Care’s business development met our expectations in the first weeks of 2013.

As discussed in the “Outlook”, demand for our dialysis products and services worldwide continues to be high. Overall, the Management Board again assessed the Company’s business development as positive when this annual report was compiled. From today’s perspective, we expect to achieve our revenue, earnings and the other performance ratios as planned. At this report’s editorial deadline, the current development of our business is basically in line with our expectations.

back